This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) slid 2.86% to $1.70 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.59% to 23,057.41 and Dow Jones Industrial Average  falling 0.09% to 48,416.56.
This was the stock's third consecutive day of losses.
TherapeuticsMD Inc. closed 30.33% below its 52-week high of $2.44, which the company achieved on January 3rd.
The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc. (ABBV) rose 1.85% to $227.45.
Trading volume (44,356) remained 239,281 below its 50-day average volume of 283,637.
Data source: Dow Jones Market Data, FactSet. Data compiled December 15, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-15-25 1732ET

TXMD

<p>TherapeuticsMD Inc. (TXMD) shares fell 2.86% to $1.70 on Monday, marking the third consecutive day of losses. The stock underperformed compared to competitors like AbbVie Inc., which rose 1.85%. TXMD is 30.33% below its 52-week high of $2.44. Trading volume was significantly below the 50-day average. The NASDAQ Composite and Dow Jones Industrial Average also declined.</p>

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors